RSIP Vision: An Innovative Set of AI Modules for Enhanced Medical Ultrasound Applications is Introduced

June 22, 2020

RSIP Vision has announced a new set of AI-based medical ultrasound modules.

RSIP Vision notes these advanced modules will serve as AI-based building blocks for a variety of applications, ranging from automated diagnosis, measurement, and volume estimation, to advanced procedure planning and in-op guided tracking.

When integrated into third-party ultrasound carts, PACS systems, and proprietary cloud platforms, these modules will enable a new set of innovative capabilities in a wide range of domains, such as urology, OBGYN, general imaging, cardiac procedures, and more.

These new building blocks will enable new applications, including:

Biopsy guidance – The modules allow for real-time, AI-guided needle biopsy procedures, while providing an improved understanding of the lesion or mass. They utilize automated tissue segmentation capabilities, clearly separate the abnormal tissue from the healthy one, and provide the surgeon with all the necessary data required to get to the desired area quickly and precisely.

Automated measurements and function evaluation in Cardiac Ultrasound – These AI modules perform fully automated segmentation of the heart chambers from different ultrasound views, which automates the most important measurements, such as Ejection Fraction, CO, EDA, and EDA. It also evaluates the performance of main heart functions, such as motion of the valves and walls, and detects and classifies abnormalities.

3D Reconstruction – In many cases, the sonographer will be able to demonstrate only a few slices of the organ at focus. The reconstruction function can build the complete organ from sparse information and help the interventional surgeon navigate accurately for biopsy or ablation procedures.

Patient Screening – Integrated into cloud-based settings, these AI capabilities can perform automated analysis of ongoing ultrasound studies, provide triage and second-opinion analysis, detect irregularities and potential errors, prioritize workflow, and boost population healthcare management capabilities.

“Ultrasound is extremely user-dependent and can be challenging to interpret. These innovative AI modules help medical teams make quick and accurate clinical decisions and lower the dependence on teams’ experience,” says Dr. Rabeeh Fares, Radiologist; Department of Diagnostic Radiology, Sourasky Medical Center, Tel Aviv, Israel.

The usage of ultrasound imaging plays a crucial role in the diagnosis and treatment of many pathologies. Its wide availability and relatively low cost, with no radiation considerations, makes it the preferred imaging modality across a number of clinical fields. It can immediately detect pathologies and injuries across the entire healthcare pathway and is useful in a variety of settings, from ER triage and intensive care units to point-of-care settings and outpatient clinics.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version